BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33773916)

  • 21. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
    Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL
    Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary urothelial carcinoma of the upper tract: important clinicopathological factors predicting bladder recurrence after surgical resection.
    Huang WW; Huang HY; Liao AC; Shiue YL; Tai HL; Lin CM; Wang YH; Lin CN; Shen KH; Li CF
    Pathol Int; 2009 Sep; 59(9):642-9. PubMed ID: 19712132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and demographic characteristics among patients with urothelial carcinomas of the upper urinary tract and bladder in Taiwan.
    Shen CH; Chiou HY; Tung MC; Wu CC; Kao WT; Wang YH; Juang GD
    J Chin Med Assoc; 2017 Sep; 80(9):563-568. PubMed ID: 28751166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract.
    Lee HY; Yeh BW; Chan TC; Yang KF; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Liang PI; Shiue YL; Wu WJ; Li CF
    Oncotarget; 2017 Jul; 8(29):47216-47229. PubMed ID: 28525382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site-specific differences in survival among upper and lower tract urothelial carcinoma patients treated with radical surgery.
    Anno T; Kikuchi E; Shigeta K; Ogihara K; Watanabe K; Yanai Y; Takamatsu K; Hasegawa S; Masuda T; Oyama M; Mizuno R; Oya M
    Jpn J Clin Oncol; 2021 May; 51(6):984-991. PubMed ID: 33589927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.
    Li WM; Wei YC; Huang CN; Ke HL; Li CC; Yeh HC; Chang LL; Huang CH; Li CF; Wu WJ
    J Surg Oncol; 2016 May; 113(6):700-7. PubMed ID: 26861489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urothelial carcinoma of the bladder with transmural and direct prostatic stromal invasion: does extent of stromal invasion significantly impact patient outcome?
    Oliva IV; Smith SL; Chen Z; Osunkoya AO
    Hum Pathol; 2011 Jan; 42(1):51-6. PubMed ID: 20870265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of beta-human chorionic gonadotropin (beta-hCG) in non-trophoblastic elements of transitional cell carcinoma of the bladder: possible relationship with the prognosis.
    Bacchi CE; Coelho KI; Goldberg J
    Rev Paul Med; 1993; 111(3):412-6. PubMed ID: 8108635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy.
    Wu P; Liu S; Zhang W; Zhang Y; Zhu G; Wei D; Wan B; Wang J
    Jpn J Clin Oncol; 2015 Dec; 45(12):1175-81. PubMed ID: 26450700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced expression of GATA3 predicts progression in non-muscle invasive urothelial carcinoma of the urinary bladder.
    Kamel NA; Abdelzaher E; Elgebaly O; Ibrahim SA
    J Histotechnol; 2020 Mar; 43(1):21-28. PubMed ID: 31551051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder.
    Calvete J; Larrinaga G; Errarte P; Martín AM; Dotor A; Esquinas C; Nunes-Xavier CE; Pulido R; López JI; Angulo JC
    Hum Pathol; 2019 Sep; 91():61-68. PubMed ID: 31279874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
    Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
    BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavior of urothelial carcinoma with respect to anatomical location.
    Catto JW; Yates DR; Rehman I; Azzouzi AR; Patterson J; Sibony M; Cussenot O; Hamdy FC
    J Urol; 2007 May; 177(5):1715-20. PubMed ID: 17437794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trophoblastic metaplasia in urothelial carcinoma of the bladder.
    Burry AF; Munn SR; Arnold EP; McRae CU
    Br J Urol; 1986 Apr; 58(2):143-6. PubMed ID: 2421816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract.
    Lee HY; Li CC; Huang CN; Li WM; Yeh HC; Ke HL; Yang KF; Liang PI; Li CF; Wu WJ
    J Surg Oncol; 2015 Mar; 111(4):414-22. PubMed ID: 25488476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Placental proteins in high-grade urothelial neoplasms. An immunohistochemical study of human chorionic gonadotropin, human placental lactogen, and pregnancy-specific beta-1-glycoprotein.
    Campo E; Algaba F; Palacin A; Germa R; Sole-Balcells FJ; Cardesa A
    Cancer; 1989 Jun; 63(12):2497-504. PubMed ID: 2655871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glandular differentiation in pT1 urothelial carcinoma of bladder predicts poor prognosis.
    Zhao G; Wang C; Tang Y; Liu X; Liu Z; Li G; Mei Y
    Sci Rep; 2019 Mar; 9(1):5323. PubMed ID: 30926888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
    Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
    Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HAS3 underexpression as an indicator of poor prognosis in patients with urothelial carcinoma of the upper urinary tract and urinary bladder.
    Chang IW; Liang PI; Li CC; Wu WJ; Huang CN; Lin VC; Hsu CT; He HL; Wu TF; Hung CH; Li CF
    Tumour Biol; 2015 Jul; 36(7):5441-50. PubMed ID: 25934334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.